receivedUSFDAApprovalFor

P149280
predicate

Indicates that an entity has obtained official approval from the U.S. Food and Drug Administration (FDA) for a specific product, use, or application.

Observed surface forms (3)

Surface form Occurrences
regulatoryApprovalFrom 5
FDAApprovedFor 2
approvedForMedicalUseIn 1

Sample triples (11)

Subject Object
LOXO-292 metastatic RET fusion-positive non-small cell lung cancer
LOXO-292 advanced or metastatic RET-mutant medullary thyroid cancer
LOXO-292 advanced or metastatic RET fusion-positive thyroid cancer
Vivitrol treatment of alcohol dependence via predicate surface "FDAApprovedFor"
Vivitrol prevention of relapse to opioid dependence after opioid detoxification via predicate surface "FDAApprovedFor"
Cipla US Food and Drug Administration via predicate surface "regulatoryApprovalFrom" NERFINISHED
Cipla European Medicines Agency via predicate surface "regulatoryApprovalFrom" NERFINISHED
Cipla World Health Organization Prequalification Programme via predicate surface "regulatoryApprovalFrom" NERFINISHED
Jazz Pharmaceuticals U.S. Food and Drug Administration via predicate surface "regulatoryApprovalFrom" NERFINISHED
Jazz Pharmaceuticals European Medicines Agency via predicate surface "regulatoryApprovalFrom" NERFINISHED
lamotrigine 1994 in the United States via predicate surface "approvedForMedicalUseIn"